Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling. | Biochem Pharmacol | 2026 | 42013957 | PubTator, text mining | PubMed |
| LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer. | Cancer Discov | 2026 | 42008781 | PubTator, text mining | PubMed |
| Role of the WNT signalling pathway in physiological and pathological blood-brain barrier. | Ann Med | 2026 | 42007489 | PubTator, text mining | PubMed |
| Genetic analysis and clinical phenotype of pulmonary arterial hypertension in an Algerian population. | Ann Saudi Med | 2026 | 42001268 | PubTator, text mining | PubMed |
| Immunophenotypic assessment of pure embryonal carcinoma and yolk sac tumour suggests that reprogramming to non-seminoma occurs outside the spermatogonial niche. | Histopathology | 2026 | 41988850 | PubTator, text mining | PubMed |
| SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype. | Int J Cardiol | 2026 | 41966409 | PubTator, text mining | PubMed |
| Enhancing reprogramming towards induced human expanded pluripotency through substitution of SOX2 with engineered SOX17 transcription factors. | Commun Biol | 2026 | 41957290 | PubTator, text mining | PubMed |
| [Clear cell adenocarcinoma of the urinary tract: a clinicopathological analysis of nine cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41956744 | PubTator, text mining | PubMed |
| Human receptive endometrial assembloid for deciphering the implantation window. | Elife | 2026 | 41920166 | PubTator, text mining | PubMed |
| RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation. | Nucleic Acids Res | 2026 | 41914497 | PubTator, text mining | PubMed |
| A spatiotemporal transcriptomic atlas of porcine (Sus scrofa) female early gonadal development. | Commun Biol | 2026 | 41906042 | PubTator, text mining | PubMed |
| Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer. | Curr Issues Mol Biol | 2026 | 41899426 | PubTator, text mining | PubMed |
| Future Prospects of Imatinib in Advanced Pulmonary Hypertension Management. | IUBMB Life | 2026 | 41885124 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer. | Cancer Biol Ther | 2026 | 41879036 | PubTator, text mining | PubMed |
Melanomas arising in blue nevi exhibit absence of TERT promoter mutations, low tumor mutational burden, and high frequency of distant metastases and disease-related mortality: a clinicopathologic and molecular study of 11 cases. | Virchows Arch | 2026 | 41872493 | PubTator, text mining | PubMed |
| Evaluation of DNA Methylation in TAC1, SOX17, and RASSF1A for the Early Diagnosis of Lung Cancer. | Cancer Manag Res | 2026 | 41869572 | PubTator, text mining | PubMed |
| Investigating the role of FKBP4 in testis germ cell tumor via integrated in silico approach. | In Silico Pharmacol | 2026 | 41858337 | PubTator, text mining | PubMed |
| Fine-tuning ERK activity enables proliferation-differentiation balance during lineage specification of human embryonic stem cells. | PLoS Biol | 2026 | 41843632 | PubTator, text mining | PubMed |
| Comprehensive immunohistochemical and molecular characterization of paratesticular clear cell papillary cystadenomas: A multi-institutional study of 14 cases. | Ann Diagn Pathol | 2026 | 41818879 | PubTator, text mining | PubMed |
| Combined assessment of ERO1A expression and CD163+ tumor-associated macrophage infiltration is superior to traditional assessment methods in predicting clear cell renal cell carcinoma prognosis. | Front Oncol | 2026 | 41809819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=3